Plain-English translation of NCT07406048 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study that follows patients already taking Trimbow (a triple-combination inhaler containing three different medicines) to see how well it works for severe COPD in everyday clinical practice. Researchers will collect information from your medical records before and after you start the medication to understand its effectiveness and safety in Brazilian patients with advanced lung disease.
COPD is a serious lung condition that gets worse over time, and doctors need to know how well newer combination treatments work in real-world patients outside of controlled clinical trials. This study will help doctors understand whether this medication is effective at reducing breathing problems and flare-ups in people with severe COPD.
You likely qualify if…
You likely don't qualify if…
You will continue taking your medication as your doctor prescribes—the study does not provide or change your treatment. Researchers will collect information from your medical records and have you complete routine clinic visits at baseline, around 3 months, and 6 months. The visits are part of your normal COPD care, and you'll be asked to answer questions about your symptoms and how well you're breathing.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Brazil